These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36420784)

  • 1. Pineapple Lectin AcmJRL Binds SARS-CoV-2 Spike Protein in a Carbohydrate-Dependent Fashion.
    Meiers J; Dastbaz J; Adam S; Rasheed S; Kirsch SH; Meiser P; Gross P; Müller R; Titz A
    Chembiochem; 2023 Feb; 24(3):e202200463. PubMed ID: 36420784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and structural characterization of a mannose binding jacalin-related lectin with two-sugar binding sites from pineapple (Ananas comosus) stem.
    Azarkan M; Feller G; Vandenameele J; Herman R; El Mahyaoui R; Sauvage E; Vanden Broeck A; Matagne A; Charlier P; Kerff F
    Sci Rep; 2018 Jul; 8(1):11508. PubMed ID: 30065388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
    Barre A; Van Damme EJM; Simplicien M; Le Poder S; Klonjkowski B; Benoist H; Peyrade D; Rougé P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34203435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting spike glycans to inhibit SARS-CoV2 viral entry.
    Guseman AJ; Rennick LJ; Nambulli S; Roy CN; Martinez DR; Yang DT; Bhinderwala F; Vergara S; Schaefer A; Baric RS; Ambrose Z; Duprex WP; Gronenborn AM
    Proc Natl Acad Sci U S A; 2023 Sep; 120(38):e2301518120. PubMed ID: 37695910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant lectins as versatile tools to fight coronavirus outbreaks.
    Simplicien M; Pério P; Sudor J; Barre A; Benoist H; Van Damme EJM; Rougé P
    Glycoconj J; 2023 Feb; 40(1):109-118. PubMed ID: 36418811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.
    Nangarlia A; Hassen FF; Canziani G; Bandi P; Talukder C; Zhang F; Krauth D; Gary EN; Weiner DB; Bieniasz P; Navas-Martin S; O'Keefe BR; Ang CG; Chaiken I
    Biochemistry; 2023 Jul; 62(14):2115-2127. PubMed ID: 37341186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensing the interactions between carbohydrate-binding agents and
    Lokhande KB; Apte GR; Shrivastava A; Singh A; Pal JK; K Venkateswara Swamy ; Gupta RK
    J Biomol Struct Dyn; 2022 Jun; 40(9):3880-3898. PubMed ID: 33292056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering recombinantly expressed lectin-based antiviral agents.
    Maier I
    Front Cell Infect Microbiol; 2022; 12():990875. PubMed ID: 36211961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.
    Barre A; Damme EJMV; Simplicien M; Benoist H; Rougé P
    Mar Drugs; 2020 Oct; 18(11):. PubMed ID: 33138151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
    Muñoz-Basagoiti J; Monteiro FLL; Krumpe LRH; Armario-Najera V; Shenoy SR; Perez-Zsolt D; Westgarth HJ; Villorbina G; Bomfim LM; Raïch-Regué D; Nogueras L; Henrich CJ; Gallemí M; Moreira FRR; Torres P; Wilson J; D'arc M; Marfil S; Herlinger AL; Pradenas E; Higa LM; Portero-Otin M; Trinité B; Twyman RM; Capell T; Tanuri A; Blanco J; Izquierdo-Useros N; Rech EL; Christou P; O'Keefe BR
    Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2214561120. PubMed ID: 36853940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
    Pollastri S; Delaunay C; Thépaut M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2022 Apr; 58(33):5136-5139. PubMed ID: 35380569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectins and lectibodies: potential promising antiviral agents.
    Nabi-Afjadi M; Heydari M; Zalpoor H; Arman I; Sadoughi A; Sahami P; Aghazadeh S
    Cell Mol Biol Lett; 2022 May; 27(1):37. PubMed ID: 35562647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate Ligands for COVID-19 Spike Proteins.
    Lee YK; Chang WC; Prakash E; Peng YJ; Tu ZJ; Lin CH; Hsu PH; Chang CF
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses.
    Barre A; Van Damme EJM; Klonjkowski B; Simplicien M; Sudor J; Benoist H; Rougé P
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
    Byrd-Leotis L; Lasanajak Y; Bowen T; Baker K; Song X; Suthar MS; Cummings RD; Steinhauer DA
    Virology; 2021 Oct; 562():142-148. PubMed ID: 34325286
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Pandey AK; Verma S
    Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
    Chan JF; Oh YJ; Yuan S; Chu H; Yeung ML; Canena D; Chan CC; Poon VK; Chan CC; Zhang AJ; Cai JP; Ye ZW; Wen L; Yuen TT; Chik KK; Shuai H; Wang Y; Hou Y; Luo C; Chan WM; Qin Z; Sit KY; Au WK; Legendre M; Zhu R; Hain L; Seferovic H; Tampé R; To KK; Chan KH; Thomas DG; Klausberger M; Xu C; Moon JJ; Stadlmann J; Penninger JM; Oostenbrink C; Hinterdorfer P; Yuen KY; Markovitz DM
    Cell Rep Med; 2022 Oct; 3(10):100774. PubMed ID: 36195094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.